KGWV · U.S. MARKET INTELLIGENCE
Latest close on August 11, 2026: $941.04 (-1.2% on the latest daily bar). HMA21 / HMA55: $952.49 / $940.92. 200DMA: $958.14. Relative volume: 0.34x the 20-day average. Latest comparable filing period: 2026 Q3 ending 2026-05-10; filed 2026-06-03. Comparable gro…
The composition of U.S. Treasury buyers is shifting toward value-conscious mutual funds, households and other private investors, a change that has helped push the 30-year Treasury yield to levels near multidecade highs, Barclays said. Strategists Demi Hu and A…
Reports about Nvidia’s potential $500 billion financing plan, along with an announcement first released Monday evening, provided few details about the timing and structure of the transaction, leaving investors eager to assess its potential impact on the compan…
Over the past 24 hours, the MarketVector™ Digital Asset 100 Small Cap Index fell 0.43% to 2,072.69. It edged up to 2,090.82 at 6:14 a.m. Beijing time, setting the day’s high, before falling rapidly and reaching the day’s low of 2,052.06 at 8 a.m. The MarketVec…
Nvidia shares rose nearly 2% in premarket trading after The Information, citing several unnamed people involved in the Nemotron project, reported that the company is developing an ambitious new open-source artificial intelligence model called Nemotron 4. Sever…
Citi added MongoDB to its 90-day upside catalyst watch list, saying the company could continue to see significant positive earnings estimate revisions and that multiple positive catalysts may emerge over the coming months. Citi rates MongoDB Buy and has a $545…
U.S. stocks opened mixed on Aug. 11. The S&P 500 rose 14.40 points, or 0.19%, to 7,767.51, while the Dow Jones Industrial Average fell 14.38 points, or 0.03%, to 53,961.60. The Nasdaq Composite gained 66.82 points, or 0.25%, to 26,672.17.
U.S. markets are at historic highs, but concerns ranging from geopolitics and inflation to divisions within the Federal Reserve are curbing investors’ appetite for risk. That may be precisely what this rally needs to continue. New money is flowing into passive…
Jazz Pharmaceuticals will acquire Actio Biosciences for $820 million in upfront cash, expanding its pipeline of treatments for rare epilepsies. The deal centers on Actio’s lead drug, ABS-1230, an oral precision therapy for epilepsy associated with KCNT1 mutati…
price=26.524999618530273 hma21=26.405213827818507 hma55=25.333468572827847 sma200=25.88552502632141 Revenue YoY=2.6001501399030915; net income YoY=-108.52233676975945; EPS YoY=-107.84313725490198 trailing_pe=34.901318; forward_pe=9.17401; enterprise_to_ebitda=…